← Leaderboards
Benjamin Patrick Brown
Vanderbilt University
$1,588,215
Attributed
$1,588,215
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $475.5K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,588,215 · 2
By mechanism
DP1$1,426,500 · 1
F30$161,715 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- C David Weaver$15,228,291
- Jerri Michelle Rook$4,711,471
- P Jeffrey Conn$37,782,937
- Jerod S Denton$12,278,378
- Craig Lindsley$38,671,033
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationComputer AssistedTargeted TreatmentCollaborationsLigandsDockingDrug DiscoveryMolecular ConformationStructureDesignSmall MoleculeProteinsAlgorithmsIn SilicoBiochemicalDiscoidin Domain Receptor 1Binding SitesCollagenBinding ProteinsDiscoidin Domain Receptor 2BindingAgedClinically RelevantChronic Kidney Failure
Grant awards (7)
Developing a computational platform for induced-fit and chemogenetic drug design$475,500
DP1 · FY2025 · DA · contact PI
Developing a computational platform for induced-fit and chemogenetic drug design$475,500
DP1 · FY2024 · DA · contact PI
Developing a computational platform for induced-fit and chemogenetic drug design$475,500
DP1 · FY2023 · DA · contact PI
Targeting receptor tyrosine kinases with novel methods in computer-aided drug discovery for the treatment of fibrotic renal disease$51,036
F30 · FY2021 · DK · contact PI
Targeting receptor tyrosine kinases with novel methods in computer-aided drug discovery for the treatment of fibrotic renal disease$47,875
F30 · FY2020 · DK · contact PI
Targeting receptor tyrosine kinases with novel methods in computer-aided drug discovery for the treatment of fibrotic renal disease$31,648
F30 · FY2019 · DK · contact PI
Targeting receptor tyrosine kinases with novel methods in computer-aided drug discovery for the treatment of fibrotic renal disease$31,156
F30 · FY2018 · DK · contact PI